XENE — Xenon Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$36.50

YTD price return

-18.56%

YTD total return

-18.56%

Next earnings

Nov 2, 2026

Market cap

3.5B2016-12 137.8M2026-10 3.5B+2465.5% over the window

Enterprise value

2.6B

Shares outstanding

96.8M2016-06 14.4M2026-06 96.8M+571.3% over the window

52W low

$33.38

52W high

$72.66

From 52W high

-49.77%

From 52W low

+9.35%

52W range

8%

Volume

Rel volume

0.58×

30D volume

2.4M

30D $ vol

92.3M

Fundamentals

EPS (ttm)

-$4.732016-06 -$1.192026-06 -$4.73+297.1% over the window

FCF (ttm)

-338.5M2016-06 -21.1M2026-06 -338.5M+1506.6% over the window

FCF/share

-$3.502016-06 -$1.462026-06 -$3.50+139.3% over the window

Book value/share

$12.832016-06 $3.652026-06 $12.83+251.5% over the window

ROE

-32.94%2016-06 -32.4%2026-06 -32.9%+1.8% over the window

ROA

-31.58%2016-06 -30.6%2026-06 -31.6%+3.2% over the window

Current ratio

21.022016-06 18.232026-06 21.02+15.3% over the window

Growth (CAGR, ttm) · 10Y

Shares

+25.61%2025-06-30 → 2026-06-3077.1M → 96.8M (+25.6% total)+14.71%2023-06-30 → 2026-06-3064.1M → 96.8M (+51.0% total)+18.69%2021-06-30 → 2026-06-3041.1M → 96.8M (+135.5% total)+20.98%2016-06-30 → 2026-06-3014.4M → 96.8M (+571.3% total)

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+56.08%2025-06-30 → 2026-06-30$8.22 → $12.83 (+56.0% total)+8.38%2023-06-30 → 2026-06-30$10.08 → $12.83 (+27.3% total)+15.47%2021-06-30 → 2026-06-30$6.25 → $12.83 (+105.3% total)+13.40%2016-06-30 → 2026-06-30$3.65 → $12.83 (+251.5% total)

Price

-13.47%2025-10-22 → 2026-10-22$42.18 → $36.50 (-13.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.74%2023-10-23 → 2026-10-22$32.70 → $36.50 (+11.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.41%2021-10-22 → 2026-10-22$30.86 → $36.50 (+18.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.62%2016-10-21 → 2026-10-22$8.55 → $36.50 (+326.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-13.47%2025-10-22 → 2026-10-22$42.18 → $36.50 (-13.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.74%2023-10-23 → 2026-10-22$32.70 → $36.50 (+11.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.41%2021-10-22 → 2026-10-22$30.86 → $36.50 (+18.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.62%2016-10-21 → 2026-10-22$8.55 → $36.50 (+326.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-7.7×2016-12 -6.582026-10 -8.64+31.2% over the window

Fwd P/E

-7.4×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.8×2016-12 1.992026-10 2.85+43.1% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-9.58%2016-09 -14.9%2026-06 -5.8%-61.1% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 96.8M ÷ 77.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-25.61%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-25.61%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-25.61%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2016-09 -17.3%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3.5B). Same caveat as the cash buyback yield.

0.00%2016-09 -17.3%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S

83rd

P/B

38th